Notice ID: d417ec17a5554633bfb196f4cad27ce2Combined Synopsis/Solicitation
Next Generation Sequencing (NGS) in Psychiatric Disorders
Archived on September 5, 2020. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 12:00 PM UTC−04:00
- Posted
- August 21, 2020
- Notice type
- Combined Synopsis/Solicitation
- Set-aside
- Total Small Business Set-Aside (FAR 19.5)
- NAICS
- 541380: Testing Laboratories and Services
- Agency
- Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH
Notice details
- Office
- NATIONAL INSTITUTES OF HEALTH NIDA
- Last updated
- Apr 29, 2026
Identifiers
- Solicitation number
- NIMH-20-004388
- Notice ID
- d417ec17a5554633bfb196f4cad27ce2
Description
Next Generation Sequencing (NGS) in Psychiatric Disorders Competitive Combined Synopsis/Solicitation NIMH-20-004388 INTRODUCTION This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. This acquisition is being conducted in accordance with the procedures of FAR Part 13--Simplified Acquisition Procedures. The solicitation number is NIMH-20-004388 and the solicitation is issued as a request for quotation (RFQ). NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE The intended procurement is classified under NAICS code 541380 with a size standard of $16.5 million is being considered. SET-ASIDE STATUS This is a small business set aside. ACQUISITION AUTHORITY This acquisition is for a commercial item or service and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13 Simplified Acquisition Procedures and FAR Part 12 Acquisition of Commercial Items and is not expected to exceed the simplified acquisition threshold. The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2020-08 dated August 13, 2020. The resultant contract will include all applicable provisions and clauses in effect through this date. DESCRIPTION OF REQUIREMENT Background HGB investigates the genetic basis of mood and anxiety disorders. In this regard, we have been collecting the DNA and RNA from individuals and their family members with mood and anxiety disorders. During the base year the program will need sequencing on DNA using exome sequencing on 140 samples and whole genome sequencing on 47 samples, and sequencing the RNA using RNA sequencing on 116 samples. By using multiple techniques, we will be able to find the genes responsible for these devastating mental disorders. During the option period the program will require sequencing on DNA using exome sequencing on 70 samples and whole genome sequencing on 20 samples, and sequencing the RNA using RNA sequencing on 58 samples. Project Requirements See Attached Purchase Description for details. Delivery Requirements/Period of Performance Base Period: 9/1/2020 8/31/2021 Option Period 1: 9/1/2021 8/31/2022 Contract Type The Government intends to issue a firm fixed price purchase order for this requirement. Invoicing shall be in accordance with the Prompt Payment Act and payment shall be made via Electronic Funds Transfer (EFT). Response Format Responses to this solicitation must include clear and convincing evidence of the offeror's capability of fulfilling the requirement as it relates to the technical evaluation criteria. The contractor must submit (1) a technical proposal and (2) a price proposal. The price proposal must include the costs per test, breakdown and rationale for other direct costs or materials shipping and catalog pricing, and the total amount. Technical Proposal: The offerors technical proposal shall demonstrate the offerors technical understanding of the tasks outlined in the description of the requirement. The offerors technical proposal shall not exceed five pages. Price Proposal: The offerors price proposal must include the costs per test, breakdown and rationale for other direct costs or materials shipping and catalog pricing, and the total amount. Submit an executed copy of FAR 52.204-24 Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment (AUG 2020) (Attachment 5) An award will be made to the offeror whose proposal represents the best value to the Government. (Attachment 3) In addition, the quote must provide their company name, Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size must be included in the response. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov. EVALUATION Offers will be evaluated for technical criteria, price, and past performance using a comparative approach. A contract will be awarded to the offer that is determined to be most advantageous to the Government. Responses to this solicitation must address the Technical Evaluation Criteria set forth in Attachment 2. ADDITIONAL INFORMATION FAR 52.252-2 CLAUSES INCORPORATED BY REFERENCE (FEB 1998) This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at this/these address(es): http://www.acquisition.gov/far/ and/or http://www.hhs.gov/policies/hhsar/. The Offerors to include a signed copy of the provision at FAR clause 52.204-24 Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment (AUG 2019), with its offer. The Offerors to include a signed copy of the provision at FAR clause 52.204-26 Covered Telecommunications or Services Representation (Dec 2019), with its offer. FAR 52.212-1 Instructions to Offerors Commercial Items (OCT 2018) The Offerors to include a completed copy of the provision at FAR clause 52.212-3, Offeror Representations and Certifications-Commercial Items, with its offer. The FAR clause at 52.212-4, Contract Terms and Conditions Commercial Items. See Clauses attachment. FAR clause at 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders-Commercial Items, applies to this acquisition. See clauses attachment. The following FAR clauses cited in paragraph (b) of the clause at FAR 52.212-5 are also applicable to this acquisition: FAR Clause 52.204-10 Reporting Executive Compensation and First Tier Subcontract Awards FAR Clause 52.209-6 Protecting the Government's Interest When Subcontracting with Contractors Debarred, Suspended, or Proposed for Debarment FAR Clause 52.209-9 Updates of Publicly Available Information Regarding Responsibility FAR Clause 52.219-28 Post Award Small Business Program Representation FAR Clause 52.222-3 Convict Labor FAR Clause 52.222-19 Child Labor-Cooperation with Authorities and Remedies FAR Clause 52.222-21 Prohibition of Segregated Facilities FAR Clause 52.222-26 Equal Opportunity FAR Clause 52.222-36 Affirmative Action for Workers with Disabilities FAR Clause 52.222-40 Notification of Employee Rights Concerning Payment of Union Dues or Fees FAR Clause 52.223-18 Encouraging Contractor Policies to Ban Text Messaging while Driving FAR Clause 52.225-3 Buy American Act -Free Trade Agreements - Israeli Trade Act FAR Clause 52.225-13 Restrictions on Certain Foreign Purchases FAR Clause 52.232-33 Payment by Electronic Funds Transfer-System for Award Management The Defense Priorities and Allocations System (DPAS) are not applicable to this requirement. CLOSING INFORMATION All responses must be received by 12:00 PM, Monday, August 21, 2020 and reference number NIMH-20-004388. Responses may be submitted electronically to michellececilia.cecilia@nih.gov, and valerie.whipple@nih.gov. Any questions must be submitted by 12:00 PM EST on Thursday, August 25, 2020. Fax responses will not be accepted. ATTACHMENTS Attachment 1 Purchase Description Attachment 2 Technical Evaluation Criteria Attachment 3 Price Proposal Attachment 4 52.212-4 and 52.212-5 Attachment 5 52.204-24 Clauses Attachment 6 Invoice Instructions
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
NIMH-20-004388- Combined Synopsis
- 4×Combined SynopsisCurrentAug 14, 2020
Next Generation Sequencing (NGS) in Psychiatric Disorders
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Centers for Disease Control (CDC) is issuing this synopsis as a means of conducting market research to identify parties having an interest in and the resources to support this requirement for a California-based integrated health care system to serve as an electronic health record site in CDC’s VISION 2.0 respiratory pathogen surveillance network, providing integrated, longitudinal medical, laboratory, pharmacy, vaccination, claims, and outcomes data to support influenza surveillance, vaccine-effectiveness studies, and related respiratory pathogen research across emergency/urgent care, inpatient, and intensive care unit (ICU) settings. The result of this market research will contribute to determining the method of acquisition. The applicable North American Industry Classification System (NAICS) code assigned to this acquisition is 541380- Testing Laboratories and Services. | 61% | Market Research | 12/04/2026 |
Husbandry Animal Services | 57% | Market Research | 11/09/2026 |
Louisville VAMC seeks a contract for laboratory services to run surface sample testing and personnel aseptic technique competency testing results (gloved fingertip and thumb sampling and media fill testing) for the Pharmacy Service s sterile compounding spaces. **Solicitation closing will be moved to WED 11/04/2026 @ 1500 EST. | 57% | Solicitation | 11/04/2026 |
The South Texas Veterans Health Care System requires contractor services to perform testing and certification of sterile compounding facilities, including primary and secondary engineering controls as described in the attached Performance Work Statement (PWS), at the Audie L. Murphy Memorial VA Hospital Pharmacy Service. All work shall be performed in accordance with applicable standards and the related testing described in the attached PWS. The contractor shall provide all labor, equipment, and documentation needed to fulfill the requirements outlined in the PWS. | 57% | Combined Synopsis | 11/17/2026 |
Louisville VAMC seeks a contract for laboratory services to run surface sample testing and personnel aseptic technique competency testing results (gloved fingertip and thumb sampling and media fill testing) for the Pharmacy Service s sterile compounding spaces. | 57% | Pre-Solicitation | 11/02/2026 |
Additional Details
Solicitation Number
NIMH-20-004388
Archive Date
Sep 5, 2020
Office Address
Bethesda, MD, 20892